Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis.
about
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial.Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis.Amyloidosis: pathogenesis and new therapeutic options.Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain productionThe amyloid fibrils of the constant domain of immunoglobulin light chain.Evaluation of intensive chemotherapy in AL amyloidosis: usefulness of flow cytometric analysis of plasma cells in bone marrow.
P2860
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Phase II trial of high-dose de ...... bulin light-chain amyloidosis.
@en
Phase II trial of high-dose de ...... bulin light-chain amyloidosis.
@nl
type
label
Phase II trial of high-dose de ...... bulin light-chain amyloidosis.
@en
Phase II trial of high-dose de ...... bulin light-chain amyloidosis.
@nl
prefLabel
Phase II trial of high-dose de ...... bulin light-chain amyloidosis.
@en
Phase II trial of high-dose de ...... bulin light-chain amyloidosis.
@nl
P2093
P1476
Phase II trial of high-dose de ...... bulin light-chain amyloidosis.
@en
P2093
P304
P356
10.1002/(SICI)1096-8652(199906)61:2<115::AID-AJH7>3.0.CO;2-I
P577
1999-06-01T00:00:00Z